Revolutionizing MDD Treatment through Computational Neuropsychiatry
Learn how breakthroughs in computational neuropsychiatry are shaping the future of personalized MDD treatment.
Tag: MDD
Entering the extension period for MDD legacy devices in the EU
Explore how the EU’s extension for MDD legacy devices impacts manufacturers, ensuring compliance with MDR regulations & preventing shortages.
Home-Based tDCS as a Promising Treatment for Depression
Promising results from our tDCS study suggest a new horizon for depression treatment at home. Safe, supervised, and effective.
FDA greenlights Neuroelectrics to help patients with Major Depression at home amidst Covid-19 restrictions
The FDA has given the green light to our at-home Depression therapy during COVID-19, offering personalized brain stimulation